Equillium Inc EQ.OQ EQ.O is expected to show a fall in quarterly revenue when it reports results on November 11 (estimated) for the period ending September 30 2025
LSEG's mean analyst estimate for Equillium Inc is for a loss of 14 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Equillium Inc is $2.50, about 49.4% above its last closing price of $1.27
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | -0.23 | -0.18 | -0.16 | Beat | 13.5 |
Mar. 31 2025 | -0.34 | -0.33 | -0.24 | Beat | 28.4 |
Dec. 31 2024 | -0.31 | -0.16 | Beat | 48.4 | |
Sep. 30 2024 | -0.23 | -0.26 | 0.00 | Beat | 100 |
Jun. 30 2024 | -0.13 | -0.15 | 0.01 | Beat | 106.7 |
Mar. 31 2024 | -0.15 | -0.15 | -0.08 | Beat | 45.8 |
Dec. 31 2023 | -0.17 | -0.07 | Beat | 58.2 | |
Sep. 30 2023 | -0.14 | -0.17 | -0.11 | Beat | 35.3 |
This summary was machine generated November 7 at 21:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)